Royal Biologics Acquires FIBRINET from Vertical Spine LLC

September 1, 2020

Royal Biologics, an ortho-biologics company based in Hackensack, New Jersey, completed the acquisition of the FIBRINET system from Vertical Spine LLC. The FIBRINET system uses a patient’s autologous blood to create a platelet-rich fibrin matrix (PRFM) for use in spinal fusion and expands Royal Biologics’ portfolio of autologous and live cellular therapies to support orthopedic and spinal fusion procedures.

Buyers
Royal Biologics
Targets
FIBRINET
Sellers
Vertical Spine LLC
Industry
Medical Devices
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.